Interventions
Longevity and healthspan interventions — what this site will review, and why most of this section is still empty.
This section is deliberately short. Publishing confident verdicts on longevity interventions faster than the evidence supports is the main failure mode of the category, and it is the one this site exists to avoid.
What belongs here
Interventions where a claim is being made to consumers and where there is a published evidence base to check it against:
- Screening programmes and diagnostic packages sold to people without symptoms
- Pharmacological interventions marketed for lifespan or healthspan extension
- Cell and infusion-based therapies offered for metabolic or age-related conditions
- Nutritional and supplement protocols promoted with outcome claims
What does not belong here
- Anything requiring an individual clinical judgement. Whether a specific intervention suits a specific person depends on their history, medications and risk profile, and cannot be answered by a verdict on a webpage.
- Anything where the only available evidence is provider-reported.
- Interventions where the outcome measured is a biomarker with no established link to how long or how well people live.
Why most of this page is a plan rather than a list
Each review takes real work: locating the trials, checking the effect sizes against the claims, and stating the uncertainty. Producing verdicts at speed would mean producing the same confident content that already exists elsewhere, with this site's badge on it.
New reviews will appear here as they are completed and reviewed. Until then, the honest state of this section is that it is being written.